Elon Musk’s brain-computer interface company, Neuralink, has successfully closed a $650 million Series E funding round, according to a blog post shared by the company on Monday. The round drew support from major investors, including ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others.
This marks a significant jump from the company’s previous Series D round in 2023, which raised $280 million, followed by an additional $43 million in subsequent months. Since that time, Neuralink has reported major progress in its brain chip technology.
The company has now implanted its neural devices in five patients suffering from severe paralysis as part of its ongoing human clinical trials. In May, Neuralink also received “breakthrough device” designation from the U.S. Food and Drug Administration (FDA), a status aimed at accelerating the development and evaluation of innovative medical technologies.
According to a report by Semafor last week, the new funding round places Neuralink’s pre-money valuation at approximately $9 billion.
